95 related articles for article (PubMed ID: 2652588)
1. Long-term clinical studies of high-risk renal retransplant recipients given total lymphoid irradiation.
Kaufman DB; Kim TH; Slavin S; Najarian JS; Sutherland DE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1798-9. PubMed ID: 2652588
[No Abstract] [Full Text] [Related]
2. Long-term follow-up of kidney grafts in high-risk patients under TLI and CsA therapy.
Cortesini R; Molajoni ER; Berloco P; Bachetoni A; Cinti P; Trovati A; Sallusto F; Pretagostini R; Iapelli M; Caricato M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1790-2. PubMed ID: 2652585
[No Abstract] [Full Text] [Related]
3. Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients.
Sonoda K; Meek AG; Strober S; Hayashi R; Ishimaru M; Rapaport FT
Transplant Proc; 1989 Feb; 21(1 Pt 1):1116-7. PubMed ID: 2650070
[No Abstract] [Full Text] [Related]
4. Wide field low-dose total lymphoid irradiation in clinical kidney transplantation.
Myburgh JA; Meyers AM; Botha JR; Thomson PD; Smit JA; Browde S; Lakier R
Transplant Proc; 1987 Feb; 19(1 Pt 3):1974-7. PubMed ID: 3547902
[No Abstract] [Full Text] [Related]
5. Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion.
Watanabe K; Yuge K; Sato K; Yamagishi K; Sonoda K; Masaki Y; Maruyama S; Takahara H; Matsubayashi T; Yago K
Transplant Proc; 1989 Feb; 21(1 Pt 1):1112-5. PubMed ID: 2468213
[No Abstract] [Full Text] [Related]
6. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
[No Abstract] [Full Text] [Related]
7. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
[No Abstract] [Full Text] [Related]
8. Successful cadaveric renal transplantation in infants and young children.
Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN
Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559
[No Abstract] [Full Text] [Related]
9. Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
Ettenger RB; Rosenthal JT; Marik J; Forsythe S; Malekzadeh MH; Kamil E; Salusky IB; Fine RN
Transplant Proc; 1989 Feb; 21(1 Pt 2):1693-5. PubMed ID: 2652554
[No Abstract] [Full Text] [Related]
10. Cadaveric kidney transplantation in diabetics after total lymphoid irradiation (TLI).
Vanrenterghem Y; Waer M; Ang K; van der Schueren E; Gruwez J; Bouillon R; Michielsen P
Transplant Proc; 1984 Jun; 16(3):636-9. PubMed ID: 6375031
[No Abstract] [Full Text] [Related]
11. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
[No Abstract] [Full Text] [Related]
12. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
13. Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.
Harland RC; Halperin EC; Yamaguchi Y; Ruiz P; Scroggs MW; Sanfilippo F; Bollinger RR
Transplant Proc; 1989 Feb; 21(1 Pt 1):1118-9. PubMed ID: 2650071
[No Abstract] [Full Text] [Related]
14. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
15. Factors determining the success rate of total lymphoid irradiation in clinical kidney transplantation.
Waer M; Leenaerts P; Vanrenterghem Y; Roels L; van der Schueren E; Vandeputte M; Michielsen P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1796-7. PubMed ID: 2652587
[No Abstract] [Full Text] [Related]
16. Inhibition of chronic kidney allograft rejection by cyclosporine.
Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Zerati-Filho M; Verona CB; Martucci RC; Bezas AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
[No Abstract] [Full Text] [Related]
17. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
18. Elective conversion from cyclosporine to azathioprine: long-term follow-up.
Veitch PS; Taylor JD; Feehally J; Walls J; Bell PR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2017. PubMed ID: 3079067
[No Abstract] [Full Text] [Related]
19. Serum beta 2 microglobulin monitoring in cadaver kidney transplant recipients with oliguric renal failure.
Schweizer RT; Roper L; Hull D; Bartus S
Transplant Proc; 1989 Feb; 21(1 Pt 2):1867-8. PubMed ID: 2652607
[No Abstract] [Full Text] [Related]
20. Total lymphoid irradiation (TLI) in the cyclosporine era--use of TLI in resistant cardiac allograft rejection.
Levin B; Bohannon L; Warvariv V; Bry W; Collins G
Transplant Proc; 1989 Feb; 21(1 Pt 2):1793-5. PubMed ID: 2652586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
